AbbVie Expands Bid to Block Qulipta Copies With Two Patent Suits - Bloomberg Law
Litigation, Intellectual Property News
AbbVie filed two new lawsuits to block generic copies of its Qulipta migraine drug. Photographer: Jamie Kelter Davis/Bloomberg. Copies of the migraine ...
